| SODIUM ACETATE | INACTIVE INGREDIENT | CIPROFLOXACIN | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | American Crew ® Anti-Dandruff + Sebum Control Shampoo | 2 |
| sodium acetate | INACTIVE INGREDIENT | These highlights do not include all the information needed to use gemcitabine for injection safely and effectively. See full prescribing information for gemcitabine for injection. Gemcitabine For Injection, Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996 | 5 |
| SODIUM ACETATE | INACTIVE INGREDIENT | Acetic Acid Otic Solution, USP | 2 |
| sodium acetate | INACTIVE INGREDIENT | H-E-B ® Allergy Relief | 1 |
| sodium acetate | INACTIVE INGREDIENT | Quality Choice ® Children's Allergy Relief | 1 |
| sodium acetate | INACTIVE INGREDIENT | Best Choice ® Children's Cetirizine | 1 |
| sodium acetate | INACTIVE INGREDIENT | Children's all day allergy | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | Ciprofloxacin Hydrochloride Ophthalmic Solution 0.3% as base Sterile | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | Octreotide Acetate Injection | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | Octreotide Acetate Injection | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | P32 Sodium Phosphate | 2 |
| SODIUM ACETATE | INACTIVE INGREDIENT | P32 Chromic Phosphate Suspension | 1 |
| sodium acetate | INACTIVE INGREDIENT | These highlights do not include all the information needed to use BYETTA safely and effectively. See full prescribing information for BYETTA. BYETTA ® (exenatide) Injection Initial U.S. Approval: 2005 | 3 |
| SODIUM ACETATE | INACTIVE INGREDIENT | Ciprofloxacin Ophthalmic Solution | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | Acetic Acid Otic Solution, USP | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | 328285dd-127a-4515-8898-dfde4ac20251 | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | 60c4d8e0-3578-4ad3-aaad-272d1c1b5afd | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | Promethazine Hydrochloride Injection, USP Rx only | 5 |
| SODIUM ACETATE | INACTIVE INGREDIENT | CIPRODEX® (ciprofloxacin 0.3% and dexamethasone 0.1%) Sterile Otic Suspension | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | These highlights do not include all the information needed to use LEVETIRACETAM safely and effectively. See full prescribing information for LEVETIRACETAM. Levetiracetam Injection for intravenous use. Initial U.S. Approval : 1999 | 2 |
| SODIUM ACETATE | INACTIVE INGREDIENT | Cetirizine HCl Drug Facts | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | These highlights do not include all the information needed to use Durezol® safely and effectively. See full prescribing information for Durezol. DUREZOL® (difuprednate ophthalmic emulsion) 0.05% Initial U.S. Approval: 2008 | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | 91bd0351-f33c-43ca-bd77-7da97969985b | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | 14b45f78-0bc0-4e25-831e-d2a0006b2b87 | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | cd6bb11b-3b9d-4d73-a093-d198913c4bff | 1 |
| sodium acetate | INACTIVE INGREDIENT | CIPROFLOXACIN HYDROCHLORIDE OPHTHALMIC SOLUTION 0.3% as base Sterile | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | Ciprofloxacin Ophthalmic SolutionUSP 0.3% as base | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | These highlights do not include all the information needed to use XYZAL safely and effectively. See full prescribing information for XYZAL. XYZAL (levocetirizine dihydrochloride) 5 mg tablets 2.5 mg/5 mL (0.5 mg/mL) oral solution Initial U.S. Approval: 1995 | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | 0084d5bc-17d5-4c58-a791-7ab3bb4590b7 | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | Promethazine Hydrochloride Injection, USP Rx only | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | Cortisporin ® -TC Otic Suspension with Neomycin and Hydrocortisone (colistin sulfate—neomycin sulfate—thonzonium bromide—hydrocortisone acetate otic suspension) | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | Promethazine Hydrochloride Injection | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | 23f3ec1c-bbba-49ef-b7d6-0be6e9424b99 | 3 |
| sodium acetate | INACTIVE INGREDIENT | Promethazine Hydrochloride Injection, USP | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | Esmolol Hydrochloride Injection | 2 |
| sodium acetate trihydrate | INACTIVE INGREDIENT | Carbastat ® | 1 |
| Sodium Acetate Trihydrate | ACTIVE INGREDIENT | PLASMA-LYTE R Injection (Multiple Electrolytes Injection, Type 2, USP) in VIAFLEX Plastic Container | 1 |
| sodium acetate | ACTIVE MOIETY | PLASMA-LYTE R Injection (Multiple Electrolytes Injection, Type 2, USP) in VIAFLEX Plastic Container | 1 |
| sodium acetate | ACTIVE MOIETY | Plasma-Lyte® 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) in Viaflex® Plastic Container | 1 |
| Sodium Acetate | ACTIVE INGREDIENT | Plasma-Lyte® 148 and 5% Dextrose Injection (Multiple Electrolytes and Dextrose Injection, Type 1, USP) in Viaflex® Plastic Container | 1 |
| SODIUM ACETATE | INACTIVE INGREDIENT | PROLIA (DENOSUMAB) INJECTION [AMGEN INC] | 147 |
| SODIUM ACETATE | INACTIVE INGREDIENT | VECTIBIX (PANITUMUMAB) SOLUTION [AMGEN INC] | 147 |
| SODIUM ACETATE | INACTIVE INGREDIENT | XGEVA (DENOSUMAB) INJECTION [AMGEN INC] | 147 |
| sodium acetate | INACTIVE INGREDIENT | PEGASYS (PEGINTERFERON ALFA-2A) KIT PEGASYS (PEGINTERFERON ALFA-2A) INJECTION, SOLUTION [GENENTECH, INC.] | 26 |
| sodium acetate | INACTIVE INGREDIENT | BONIVA (IBANDRONATE SODIUM) INJECTION, SOLUTION [GENENTECH, INC.] | 21 |
| sodium acetate | INACTIVE INGREDIENT | BYETTA (EXENATIDE) INJECTION [AMYLIN PHARMACEUTICALS, LLC] | 20 |
| SODIUM ACETATE | INACTIVE INGREDIENT | DUREZOL EMULSION [ALCON LABORATORIES, INC.] | 20 |
| sodium acetate | INACTIVE INGREDIENT | CIMZIA (CERTOLIZUMAB PEGOL) KIT CIMZIA (CERTOLIZUMAB PEGOL) INJECTION, SOLUTION [UCB, INC.] | 18 |
| Sodium acetate | INACTIVE INGREDIENT | GEMZAR (GEMCITABINE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY
] | 18 |
| SODIUM ACETATE | INACTIVE INGREDIENT | GEMCITABINE (GEMCITABINE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 16 |
| SODIUM ACETATE | INACTIVE INGREDIENT | GEMCITABINE (GEMCITABINE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 16 |
| SODIUM ACETATE | INACTIVE INGREDIENT | GEMCITABINE HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACTAVIS PHARMA, INC.] | 16 |
| SODIUM ACETATE | INACTIVE INGREDIENT | MITOXANTRONE (MITOXANTRONE HYDROCHLORIDE) INJECTION, SOLUTION, CONCENTRATE [HOSPIRA WORLDWIDE, INC.] | 16 |
| SODIUM ACETATE | ACTIVE INGREDIENT | ISOLYTE P IN DEXTROSE (DEXTROSE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, AND POTASSIUM PHOSPHATE, DIBASIC) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 15 |
| SODIUM ACETATE | INACTIVE INGREDIENT | ROCURONIUM BROMIDE INJECTION, SOLUTION [HOSPIRA, INC.] | 15 |
| SODIUM ACETATE | INACTIVE INGREDIENT | GABAPENTIN SOLUTION [HI-TECH PHARMACAL CO., INC.] | 14 |
| SODIUM ACETATE | INACTIVE INGREDIENT | ROCURONIUM BROMIDE INJECTION, SOLUTION [SANDOZ INC] | 14 |
| SODIUM ACETATE | INACTIVE INGREDIENT | GAMMAPLEX (HUMAN IMMUNOGLOBULIN G) SOLUTION [BIO PRODUCTS LABORATORY LIMITED] | 12 |
| SODIUM ACETATE | INACTIVE INGREDIENT | GEMCITABINE HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HERITAGE PHARMACEUTICALS INC.] | 11 |
| SODIUM ACETATE | ACTIVE INGREDIENT | PROCALAMINE (GLYCERIN, ISOLEUCINE, LEUCINE, LYSINE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, GLYCINE, ARGININE, HISTIDINE, PROLINE, SERINE, CYSTEINE, SODIUM ACETATE, MAGNESIUM ACETATE, CALCIUM ACETATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, PHOSPHORIC ACID, AND POTASSIUM METABISULFITE) INJECTION [B. BRAUN MEDICAL INC.] | 11 |
| SODIUM ACETATE | INACTIVE INGREDIENT | REBIF (INTERFERON BETA-1A) KIT REBIF REBIDOSE (INTERFERON BETA-1A) KIT REBIF (INTERFERON BETA-1A ) INJECTION, SOLUTION REBIF (INTERFERON BETA-1A) INJECTION, SOLUTION REBIF REBIDOSE (INTERFERON BETA-1A ) INJECTION, SOLUTION [EMD SERONO, INC.] | 11 |
| SODIUM ACETATE | INACTIVE INGREDIENT | ROCURONIUM BROMIDE INJECTION [MYLAN INSTITUTIONAL LLC] | 11 |
| sodium acetate | INACTIVE INGREDIENT | SYMLINPEN (PRAMLINTIDE ACETATE) INJECTION [AMYLIN PHARMACEUTICALS, LLC] | 11 |
| sodium acetate | INACTIVE INGREDIENT | XYZAL (LEVOCETIRIZINE DIHYDROCHLORIDE) TABLET, FILM COATED XYZAL (LEVOCETIRIZINE DIHYDROCHLORIDE) SOLUTION [SANOFI-AVENTIS U.S. LLC] | 11 |
| SODIUM ACETATE | INACTIVE INGREDIENT | BLOXIVERZ (NEOSTIGMINE METHYLSULFATE) INJECTION [ÉCLAT PHARMACEUTICALS, LLC] | 10 |
| SODIUM ACETATE | INACTIVE INGREDIENT | CETIRIZINE HYDROCHLORIDE SYRUP [PREFERRED PHARMACEUTICALS, INC] | 10 |
| SODIUM ACETATE | INACTIVE INGREDIENT | GEMCITABINE HYDROCHLORIDE (GEMCITABINE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [APP PHARMACEUTICALS, LLC] | 10 |
| SODIUM ACETATE | INACTIVE INGREDIENT | GEMCITABINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [DR. REDDY'S LABORATORIES LIMITED ] | 10 |
| sodium acetate | INACTIVE INGREDIENT | INCRELEX (MECASERMIN) INJECTION, SOLUTION [IPSEN BIOPHARMACEUTICALS, INC.] | 10 |
| sodium acetate | INACTIVE INGREDIENT | ZEMURON (ROCURONIUM BROMIDE) INJECTION, SOLUTION [ORGANON USA INC.] | 10 |
| sodium acetate | INACTIVE INGREDIENT | KEPPRA (LEVETIRACETAM) INJECTION, SOLUTION, CONCENTRATE [UCB, INC.] | 9 |
| SODIUM ACETATE | INACTIVE INGREDIENT | PROMETHAZINE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 9 |
| SODIUM ACETATE | INACTIVE INGREDIENT | PROMETHAZINE HYDROCHLORIDE INJECTION, SOLUTION [X-GEN PHARMACEUTICALS, INC.] | 9 |
| sodium acetate | INACTIVE INGREDIENT | ROCURONIUM BROMIDE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 9 |
| SODIUM ACETATE | INACTIVE INGREDIENT | ARZERRA (OFATUMUMAB) INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | 8 |
| SODIUM ACETATE | ACTIVE INGREDIENT | HYPERLYTE CR (MULTI ELECTROLYTE CONCENTRATE) INJECTION, SOLUTION, CONCENTRATE [B. BRAUN MEDICAL INC.] | 8 |
| SODIUM ACETATE | INACTIVE INGREDIENT | IBANDRONATE SODIUM INJECTION, SOLUTION [HERITAGE PHARMACEUTICALS INC.] | 8 |
| sodium acetate | INACTIVE INGREDIENT | LEVETIRACETAM INJECTION, SOLUTION, CONCENTRATE [SAGENT PHARMACEUTICALS] | 8 |
| SODIUM ACETATE | INACTIVE INGREDIENT | LEVOCETIRIZINE DIHYDROCHLORIDE SOLUTION [PERRIGO NEW YORK INC] | 8 |
| sodium acetate | INACTIVE INGREDIENT | OCTREOTIDE ACETATE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 8 |
| SODIUM ACETATE | INACTIVE INGREDIENT | VIMIZIM (ELOSULFASE ALFA) INJECTION, SOLUTION, CONCENTRATE [BIOMARIN PHARMACEUTICAL INC.] | 8 |
| SODIUM ACETATE | INACTIVE INGREDIENT | BREVIBLOC (ESMOLOL HYDROCHLORIDE) INJECTION [BAXTER HEALTHCARE CORPORATION] | 7 |
| SODIUM ACETATE | INACTIVE INGREDIENT | CETIRIZINE HYDROCHLORIDE (CETIRIZINE) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 7 |
| SODIUM ACETATE | INACTIVE INGREDIENT | CETIRIZINE HYDROCHLORIDE SYRUP [TEVA PHARMACEUTICALS USA INC] | 7 |
| sodium acetate | INACTIVE INGREDIENT | DATSCAN (IOFLUPANE I-123 AND IODINE) INJECTION, SOLUTION [MEDI-PHYSICS INC. DBA GE HEALTHCARE.] | 7 |
| sodium acetate | INACTIVE INGREDIENT | GEMCITABINE (GEMCITABINE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 7 |
| SODIUM ACETATE | INACTIVE INGREDIENT | LEVETIRACETAM INJECTION, SOLUTION, CONCENTRATE [AMERICAN REGENT, INC.] | 7 |
| SODIUM ACETATE | INACTIVE INGREDIENT | PROMETHAZINE HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 7 |
| SODIUM ACETATE | INACTIVE INGREDIENT | PROSTASCINT KIT FOR THE PREPARATION OF INDIUM IN 111 CAPROMAB PENDETIDE (CAPROMAB PENDETIDE) KIT [JAZZ PHARMACEUTICALS, INC.] | 7 |
| SODIUM ACETATE | INACTIVE INGREDIENT | ROCURONIUM BROMIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 7 |
| SODIUM ACETATE | ACTIVE INGREDIENT | BSS (BALANCED SALT SOLUTION) SOLUTION [ALCON LABORATORIES, INC.] | 6 |
| SODIUM ACETATE | INACTIVE INGREDIENT | CETIRIZINE HYDROCHLORIDE (CETIRIZINE) SOLUTION [AMNEAL PHARMACEUTICALS OF NEW YORK, LLC] | 6 |
| SODIUM ACETATE | INACTIVE INGREDIENT | CIPRO HC (CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE) SUSPENSION [ALCON LABORATORIES, INC.] | 6 |
| SODIUM ACETATE | INACTIVE INGREDIENT | GEMCITABINE HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [WATSON LABORATORIES, INC.] | 6 |
| SODIUM ACETATE | ACTIVE INGREDIENT | INTERSOL (PLATELET ADDITIVE 3) SOLUTION [FENWAL, INC.] | 6 |
| SODIUM ACETATE | INACTIVE INGREDIENT | MIACALCIN (CALCITONIN SALMON) INJECTION, SOLUTION [NOVARTIS PHARMACEUTICALS CORPORATION] | 6 |
| SODIUM ACETATE | INACTIVE INGREDIENT | ROCURONIUM BROMIDE SOLUTION [X-GEN PHARMACEUTICALS, INC.] | 6 |
| SODIUM ACETATE | INACTIVE INGREDIENT | TRIESENCE (TRIAMCINOLONE ACETONIDE) INJECTION [ALCON LABORATORIES, INC.] | 6 |
| SODIUM ACETATE | INACTIVE INGREDIENT | ACETIC ACID SOLUTION [QUALITEST PHARMACEUTICALS] | 5 |
| SODIUM ACETATE | INACTIVE INGREDIENT | APRACLONIDINE SOLUTION [FALCON PHARMACEUTICALS, LTD.] | 5 |
| Sodium Acetate | ACTIVE INGREDIENT | BALANCED SALT (CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ACETATE, SODIUM CHLORIDE, SODIUM CITRATE) SOLUTION [AKORN, INC.] | 5 |
| SODIUM ACETATE | INACTIVE INGREDIENT | CETIRIZINE HYDROCHLORIDE (CETIRIZINE) SOLUTION [AMNEAL PHARMACEUTICALS] | 5 |
| SODIUM ACETATE | INACTIVE INGREDIENT | GEMCITABINE (GEMCITABINE HYDROCHLORIDE) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [SUN PHARMA GLOBAL FZE] | 5 |
| SODIUM ACETATE | INACTIVE INGREDIENT | GEMCITABINE HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ACCORD HEALTHCARE INC.] | 5 |
| sodium acetate | INACTIVE INGREDIENT | IBANDRONATE SODIUM INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 5 |
| Sodium Acetate | INACTIVE INGREDIENT | IBUTILIDE FUMARATE INJECTION, SOLUTION [MYLAN INSTITUTIONAL LLC] | 5 |
| SODIUM ACETATE | ACTIVE INGREDIENT | ISOLYTE S PH 7.4 (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 5 |
| SODIUM ACETATE | ACTIVE INGREDIENT | ISOPLATE (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, AND POTASSIUM PHOSPHATE, MONOBASIC) SOLUTION [TERUMO BCT LTD.] | 5 |
| SODIUM ACETATE | ACTIVE INGREDIENT | PLASMA-LYTE 148 (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE) INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION] | 5 |
| SODIUM ACETATE | ACTIVE INGREDIENT | PRENATAL PLUS (.BETA.-CAROTENE, SODIUM ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CARBONATE, FERROUS FUMARATE, ZINC OXIDE AND CUPRIC OXIDE) TABLET [SETON PHARMACEUTICALS LLC] | 5 |
| SODIUM ACETATE | INACTIVE INGREDIENT | PROMETHAZINE HYDROCHLORIDE INJECTION, SOLUTION [TEVA PARENTERAL MEDICINES, INC.] | 5 |
| SODIUM ACETATE | INACTIVE INGREDIENT | ZEVALIN (IBRITUMOMAB TIUXETAN) KIT [SPECTRUM PHARMACEUTICALS, INC.] | 5 |
| sodium acetate | INACTIVE INGREDIENT | APRACLONIDINE OPHTHALMIC (APRACLONIDINE HYDROCHLORIDE) SOLUTION/ DROPS [AKORN INC.] | 4 |
| sodium acetate | INACTIVE INGREDIENT | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) SOLUTION/ DROPS [AKORN INC.] | 4 |
| SODIUM ACETATE | INACTIVE INGREDIENT | CIPROFLOXACIN (CIPROFLOXACIN HYDROCHLORIDE) SOLUTION/ DROPS [BAUSCH & LOMB INCORPORATED] | 4 |
| SODIUM ACETATE | INACTIVE INGREDIENT | CORVERT (IBUTILIDE FUMARATE) INJECTION, SOLUTION [PHARMACIA AND UPJOHN COMPANY] | 4 |
| SODIUM ACETATE | INACTIVE INGREDIENT | IBANDRONATE SODIUM INJECTION, SOLUTION [SUN PHARMACEUTICAL INDUSTRIES LIMITED ] | 4 |
| SODIUM ACETATE | INACTIVE INGREDIENT | IOPIDINE (APRACLONIDINE HYDROCHLORIDE) SOLUTION [ALCON LABORATORIES, INC.] | 4 |
| SODIUM ACETATE | ACTIVE INGREDIENT | ISOLYTE S (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 4 |
pubchem.ncbi.nlm.nih.gov/compound/23665404
mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=237108
ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47720
precision.fda.gov/uniisearch/srs/unii/4550K0SC9B